![165038-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2022-05/165038-thumbnail-image.png?versionId=jmMMpxfqhB9tZtwUpxpH074GrBW0ixsA&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033720Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=da9aacf7809e40ecc1a89066a61756efd3b8ad60c546499dba3a55418f05c0aa&itok=aN9sTij_)
The COVID-19 pandemic caused uncertainty and changing public health recommendations across the world as our understanding of the SARS-CoV-2 virus changed. Following a preliminary assessment by the World Health Organization, non-steroidal anti-inflammatory drugs were said to worsen symptoms and should be avoided before the recommendation was subsequently revoked. There also was pain associated with infection, leading to the hypothesis that use of over-the-counter pain medication increases may correlate with increases of SARS-CoV-2 infections. Wastewater samples were collected from two communities in Tempe, AZ from December 2019 to July 2020 (n = 35) and were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) to identify levels of acetaminophen, ibuprofen and their metabolites, acetaminophen sulfate and carboxy-ibuprofen. Results showed 100% detection frequency of all analytes in all samples across the duration of the study. Mass loadings of acetaminophen (918.4 g day-1 +/- 354.8 g day-1) were higher than ibuprofen (182.9 g day-1 +/- 49.8 g day-1), potentially driven by flushing behaviors rather than consumption activities. However, ibuprofen was more heavily consumed than acetaminophen across all days of the study period. Comparisons to COVID-19 clinical cases data showed increased use in ibuprofen with increases in clinical cases loads, while acetaminophen showed no change, suggesting ibuprofen was the over the counter (OTC) medication of choice during the first wave of the pandemic.
Mental health conditions can impact college students’ social and academic achievements. As such, students may disclose mental illnesses on medical school applications. Yet, no study has investigated to what extent disclosure of a mental health condition impacts medical school acceptance. We designed an audit study to address this gap. We surveyed 99 potential admissions committee members from at least 43 unique M.D.-granting schools in the U.S. Participants rated a fictitious portion of a medical school application on acceptability, competence, and likeability. They were randomly assigned to a condition: an application that explained a low semester GPA due to a mental health condition, an application that explained a low semester GPA due to a physical health condition, or an application that had a low semester GPA but did not describe any health condition. Using ANOVAs, multinomial regression, and open-coding, we found that committee members do not rate applications lower when a mental health condition is revealed. When asked about their concerns regarding the application, 27.0% of participants who received an application that revealed a mental health condition mentioned it as a concern; 14.7% of participants who received an application that revealed a physical health condition mentioned it as a concern. Committee members were also asked about when revealing a mental health condition would be beneficial and when it would be detrimental. This work indicates that medical school admissions committee members do not exhibit a bias towards mental health conditions and provides recommendations on how to discuss mental illness on medical school applications.
Phthalates are ubiquitous in the built environment and are used across various fields, despite known endocrine disruptive properties, and other associated health hazards, including abnormalities in reproductive health and development. I investigated the presence of phthalates in the built environment using the Health Product Declaration (HPD) repository to survey for products containing these chemicals, investigated the literature for possible health effects and alternatives to phthalates, and conducted a laboratoy-based feasibility study of urinary biomarkers associated with phthalates using wastewater-based epidemiology (WBE) on a US university campus at the building-scale. Of the 5,278 products in the HPD repository, 73 contained phthalates and were most commonly found in windows, doors, flooring, sealants, insulations, and furnishings. Alternative plasticizers (cardanol, epoxidized soybean oil, hydrogenated castor oil) usage were identified in 10 products from HPD repository. The two wastewater samples analyzed by liquid chromatography-tandem mass spectrometry (LC-MS-MS) showed that dimethyl phthalate (DMP) was detectable, as well as its human metabolite, monomethyl phthalate (MMP), observed at a concentration of 163-202 ng/L. These results indicate low human exposure from the building materials in the limited convenience sample investigated. Future studies of building scale wastewater-based epidemiology are recommended to investigate these and other phthalates commonly found in the built environment, including diisononyl phthalate (DINP) and diisononyl hexahydrophthalate (DINCH).
![187840-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2023-06/187840-Thumbnail%20Image.png?versionId=gGaxqcMzCFQ3wbBMf3exyFJMhs_BEilI&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240614/us-west-2/s3/aws4_request&X-Amz-Date=20240614T234145Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=1d08fffb612b949be5df3fb48e29e293917117b16418571f77f78b043386a172&itok=uPyTvCJs)
![193028-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2024-04/193028-Thumbnail%20Image.png?versionId=suOZ9SvyI6u7CZaYkSD65wGK2NVccbLr&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T001253Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f0b12d87e667e6866ac2d046f4e163484e751719f9f953782944fc13a97e494c&itok=h1VBsWIY)
![156658-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/156658-Thumbnail%20Image.png?versionId=CYyICtgQfUuy6USlzTxpw855r.E3Zyty&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T013216Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=32f601fc3072d05490179f79cd17c658dbb0a3e8e88061bf07f96240775d537b&itok=2Xvddkmn)
![156994-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/156994-Thumbnail%20Image.png?versionId=gX0OhfU9DklSFIGkZ62T1oSSnMS4UXno&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T231102Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f3fdcf95ce1e5f252753867ad59cb68c1d0b28b135530433b2dd6150448ba17b&itok=_pTcGLnM)
![152626-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/152626-Thumbnail%20Image.png?versionId=nLQ5xxp1WSJLvBZfL.Ojnx3SxMEM__gI&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033720Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=25538fa20f39aefac74cf827b64071a9b162986ba35197fa61e3e024ac9ffc27&itok=fMOS6U1o)
![152804-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/152804-Thumbnail%20Image.png?versionId=u3vtbWbTMODPAQ5Yz4_PUcsDdf324QLh&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033720Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=0dc4c0da781988192bfb20eafbfb46c907b9ab35b52d0bd74ad80557c1f8cc72&itok=keoifvt-)
![153743-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/153743-Thumbnail%20Image.png?versionId=4QW3CgpKKuJdq2TeIAzVdzrLcx8puON6&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T232137Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=c1935598492846571c40c5e87a0f5a0f69b643907d86c0565838d88e91c41a24&itok=4xuluDJG)